Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


24.09.2018

2 Ann Surg Oncol
2 BMC Cancer
1 Cancer Lett
1 Cancer Res
2 Int J Cancer
3 J Am Acad Dermatol
1 Lancet
1 Lancet Oncol
1 Melanoma Res
1 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. LEE JS, Howard RA, Klueh MP, Englesbe MJ, et al
    The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures.
    Ann Surg Oncol. 2018 Sep 20. pii: 10.1245/s10434-018-6772.
    PubMed     Text format     Abstract available

  2. LEONG SP
    The Intraoperative Portable Gamma Camera Is an Important Adjunct to the Gamma Probe in Identifying Melanoma Sentinel Lymph Nodes.
    Ann Surg Oncol. 2018 Sep 14. pii: 10.1245/s10434-018-6755.
    PubMed     Text format    


    BMC Cancer

  3. VILLAREAL MO, Sato Y, Matsuyama K, Isoda H, et al
    Correction to: Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo.
    BMC Cancer. 2018;18:902.
    PubMed     Text format     Abstract available

  4. RETEL VP, Steuten LMG, Geukes Foppen MH, Mewes JC, et al
    Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation.
    BMC Cancer. 2018;18:895.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. SEIP K, Jorgensen K, Haselager MV, Albrecht M, et al
    "Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment".
    Cancer Lett. 2018 Sep 18. pii: S0304-3835(18)30580.
    PubMed     Text format     Abstract available


    Cancer Res

  6. DIKSHIT A, Jin YJ, Degan S, Hwang J, et al
    UBE2N promotes melanoma growth via MEK/FRA1/SOX10 signaling.
    Cancer Res. 2018 Sep 17. pii: 0008-5472.CAN-18-1040.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. CALLAHAN BM, Patel JS, Fawcett TJ, Blanck G, et al
    Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoir.
    Int J Cancer. 2018;142:988-998.
    PubMed     Text format     Abstract available

  8. DASSLER-PLENKER J, Paschen A, Putschli B, Rattay S, et al
    Direct RIG-I activation in human NK cells induces TRAIL-dependent cytotoxicity towards autologous melanoma cells.
    Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31874.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  9. CONIC RZ, Ko J, Damiani G, Funchain P, et al
    Predictors of Sentinel Lymph Node Positivity in Thin Melanoma Using the National Cancer Database.
    J Am Acad Dermatol. 2018 Sep 18. pii: S0190-9622(18)32583.
    PubMed     Text format     Abstract available

  10. SVOBODA RM, Prado G, Mirsky RS, Rigel DS, et al
    Assessment of Clinician Accuracy for Diagnosing Melanoma Based on Electrical Impedance Spectroscopy Score Plus Morphology Versus Lesion Morphology Alone.
    J Am Acad Dermatol. 2018 Sep 15. pii: S0190-9622(18)32575.
    PubMed     Text format    

  11. LO SN, Stodell M, Scolyer RA, Thompson JF, et al
    In reply to Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
    J Am Acad Dermatol. 2018 Sep 15. pii: S0190-9622(18)32504.
    PubMed     Text format    


    Lancet

  12. SCHADENDORF D, van Akkooi ACJ, Berking C, Griewank KG, et al
    Melanoma.
    Lancet. 2018;392:971-984.
    PubMed     Text format     Abstract available


    Lancet Oncol

  13. DUMMER R, Ascierto PA, Gogas HJ, Arance A, et al
    Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2018 Sep 12. pii: S1470-2045(18)30497.
    PubMed     Text format     Abstract available


    Melanoma Res

  14. SCAINI MC, Pigozzo J, Pizzi M, Manicone M, et al
    Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells.
    Melanoma Res. 2018 Sep 14. doi: 10.1097/CMR.0000000000000510.
    PubMed     Text format     Abstract available


    PLoS One


  15. Correction: Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device.
    PLoS One. 2018;13:e0204692.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. DATTA S, Misra SK, Saha ML, Lahiri N, et al
    Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
    Proc Natl Acad Sci U S A. 2018;115:8087-8092.
    PubMed     Text format     Abstract available

  17. LI J, Wu C, Wang W, He Y, et al
    Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.
    Proc Natl Acad Sci U S A. 2018;115:E2696-E2705.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: